BI Asset Management Fondsmaeglerselskab A S Has $25.56 Million Stake in The Cooper Companies, Inc. (NASDAQ:COO)

BI Asset Management Fondsmaeglerselskab A S increased its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 1,628.6% in the 4th quarter, Holdings Channel reports. The firm owned 278,052 shares of the medical device company’s stock after purchasing an additional 261,967 shares during the period. BI Asset Management Fondsmaeglerselskab A S’s holdings in Cooper Companies were worth $25,561,000 as of its most recent filing with the SEC.

A number of other large investors have also recently added to or reduced their stakes in COO. Fulton Bank N.A. raised its position in shares of Cooper Companies by 3.0% in the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after purchasing an additional 109 shares during the period. Covestor Ltd raised its holdings in Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company’s stock worth $42,000 after acquiring an additional 120 shares during the period. Torray Investment Partners LLC lifted its position in Cooper Companies by 0.8% during the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock worth $1,488,000 after acquiring an additional 132 shares during the last quarter. Mather Group LLC. lifted its position in Cooper Companies by 7.4% during the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock worth $177,000 after acquiring an additional 133 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB boosted its holdings in Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after acquiring an additional 136 shares during the period. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of NASDAQ COO opened at $79.51 on Friday. The Cooper Companies, Inc. has a one year low of $69.81 and a one year high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The business has a fifty day simple moving average of $83.06 and a 200 day simple moving average of $93.67. The firm has a market capitalization of $15.90 billion, a price-to-earnings ratio of 40.77, a PEG ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.92. The business had revenue of $964.70 million for the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on COO shares. JPMorgan Chase & Co. dropped their price objective on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Friday, March 7th. Piper Sandler reaffirmed an “overweight” rating and issued a $115.00 price target (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Stifel Nicolaus reduced their price objective on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research report on Friday, March 7th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. Finally, BNP Paribas upgraded shares of Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Cooper Companies has an average rating of “Moderate Buy” and an average price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.